Ocera Therapeutics, Inc.
Ocera Therapeutics, Inc. (OCRX) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 119 transactions totaling $105.8M, demonstrating a bullish sentiment with $105.7M in net insider flow. The most recent transaction on Dec 11, 2017 involved a transaction of 12,500 shares valued at $19.0K.
OCRX Insider Activity Summary
Who Is Buying OCRX Stock?
No significant insider buying has been recorded for OCRX in the recent period.
Who Is Selling OCRX Stock?
No significant insider selling has been recorded for OCRX in the recent period.
Is Ocera Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OCRX is bullish with an Insider Alignment Score of 100/100 and a net flow of $105.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
OCRX Frequently Asked Questions
Understanding OCRX Insider Activity
Insider trading at Ocera Therapeutics, Inc. (OCRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading OCRX stock, having executed 119 transactions in the past 90 days. The most active insider is Brian H. Dovey (Executive), who has made 7 transactions totaling $16.0M.
Related Tools
Track Ocera Therapeutics, Inc. Insider Activity
Get notified when executives and directors at OCRX file new Form 4 transactions